COMPASS FINANCIAL MANAGEMENT LLC’s Elevance Health ELV Stock Holding History

COMPASS FINANCIAL MANAGEMENT LLC’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$117K	Buy	+302	New	+$112K	0.01%	526

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

COMPASS FINANCIAL MANAGEMENT LLC's ELV Position: Q2 2026 in Review

COMPASS FINANCIAL MANAGEMENT LLC opened a new position in Elevance Health (ELV) in Q2 2026: 302 shares worth $117K. The stake represents 0.01% of the portfolio and ranks #526 among its holdings.

1,233 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

COMPASS FINANCIAL MANAGEMENT LLC held 302 shares of Elevance Health worth $117K as of Q2 2026.
Elevance Health was a new COMPASS FINANCIAL MANAGEMENT LLC position in Q2 2026.
Elevance Health made up 0.01% of COMPASS FINANCIAL MANAGEMENT LLC's portfolio in Q2 2026, its #526 holding.
1,233 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on COMPASS FINANCIAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 12 Aug 2026.